Search results
Affimed (NASDAQ:AFMD) shareholders have endured a 78% loss from investing in the stock three years...
Simply Wall St. via Yahoo Finance· 11 months agoAs every investor would know, not every swing hits the sweet spot. But really bad investments should...
Why Shares of Affimed Fell Thursday
Motley Fool· 1 year agoShares of German immuno-oncology company Affimed Therapeutics (NASDAQ: AFMD) were down a little more than 15% on Thursday afternoon. There was no big...
Surprise! These 3 Penny Stocks Have Wall Street’s Seal of Approval.
InvestorPlace via Yahoo Finance· 9 months agoAlthough relative few investors – let alone analysts hired by top research institutions – give much...
